Immunoregulatory effects of two bone-marrow hexapeptides (myelopeptides) in experimental models of immunodeficiency. 1995

A A Mikhailova, and S Y Shanurin, and R V Petrov
Department of Immunology, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, Moscow, Russia.

Myelopeptide 1 (MP-1, Phe-Leu-Gly-Phe-Pro-Thr) and myelopeptide 2 (MP-2, Leu-Val-Val-Tyr-Pro-Trp) are hexapeptides originally isolated from porcine bone-marrow cell culture. MP-1 enhanced the number of antibody-forming cells in NZB mouse spleen cells in vitro and increased the antibody production in Cy-treated (CBAxC57B1/6)F1 mice in vivo. MP-1 increased ConA-induced proliferation of both NZB spleen cells in vitro and spleen cells of Cy-treated mice in vivo. MP-1 restored polyclonal IgG synthesis depressed by PWM in the NZB spleen cell culture. MP-2 also evoked immunoregulatory effects which were less pronounced and realized at higher concentrations than effects of MP-1. Neither MP-1 nor MP-2 affected LPS-induced spleen cell proliferation in both NZB- and Cy-treated (CBAxC57B1/6)F1 mice.

UI MeSH Term Description Entries
D007074 Immunoglobulin G The major immunoglobulin isotype class in normal human serum. There are several isotype subclasses of IgG, for example, IgG1, IgG2A, and IgG2B. Gamma Globulin, 7S,IgG,IgG Antibody,Allerglobuline,IgG(T),IgG1,IgG2,IgG2A,IgG2B,IgG3,IgG4,Immunoglobulin GT,Polyglobin,7S Gamma Globulin,Antibody, IgG,GT, Immunoglobulin
D007153 Immunologic Deficiency Syndromes Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral. Antibody Deficiency Syndrome,Deficiency Syndrome, Immunologic,Deficiency Syndromes, Antibody,Deficiency Syndromes, Immunologic,Immunologic Deficiency Syndrome,Immunological Deficiency Syndromes,Antibody Deficiency Syndromes,Deficiency Syndrome, Antibody,Deficiency Syndrome, Immunological,Deficiency Syndromes, Immunological,Immunological Deficiency Syndrome,Syndrome, Antibody Deficiency,Syndrome, Immunologic Deficiency,Syndrome, Immunological Deficiency,Syndromes, Antibody Deficiency,Syndromes, Immunologic Deficiency,Syndromes, Immunological Deficiency
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008297 Male Males
D008808 Mice, Inbred CBA An inbred strain of mouse that is widely used in BIOMEDICAL RESEARCH. Mice, CBA,Mouse, CBA,Mouse, Inbred CBA,CBA Mice,CBA Mice, Inbred,CBA Mouse,CBA Mouse, Inbred,Inbred CBA Mice,Inbred CBA Mouse
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D008814 Mice, Inbred NZB An inbred strain of mouse that is widely used as a model for AUTOIMMUNE DISEASES such as SYSTEMIC LUPUS ERYTHEMATOSUS. Mice, NZB,Mouse, Inbred NZB,Mouse, NZB,Inbred NZB Mice,Inbred NZB Mouse,NZB Mice,NZB Mice, Inbred,NZB Mouse,NZB Mouse, Inbred
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009842 Oligopeptides Peptides composed of between two and twelve amino acids. Oligopeptide

Related Publications

A A Mikhailova, and S Y Shanurin, and R V Petrov
January 1997, Biopolymers,
A A Mikhailova, and S Y Shanurin, and R V Petrov
February 1995, Bioscience reports,
A A Mikhailova, and S Y Shanurin, and R V Petrov
April 1995, Biulleten' eksperimental'noi biologii i meditsiny,
A A Mikhailova, and S Y Shanurin, and R V Petrov
January 1985, Vestnik Akademii meditsinskikh nauk SSSR,
A A Mikhailova, and S Y Shanurin, and R V Petrov
July 2003, Regulatory peptides,
A A Mikhailova, and S Y Shanurin, and R V Petrov
December 2009, Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova,
A A Mikhailova, and S Y Shanurin, and R V Petrov
January 1986, Doklady Akademii nauk SSSR,
A A Mikhailova, and S Y Shanurin, and R V Petrov
February 1984, Gematologiia i transfuziologiia,
A A Mikhailova, and S Y Shanurin, and R V Petrov
January 1989, Doklady Akademii nauk SSSR,
A A Mikhailova, and S Y Shanurin, and R V Petrov
September 1990, Transplantation,
Copied contents to your clipboard!